Reduced Hepatitis B and D Viral Entry Using Clinically Applied Drugs as Novel Inhibitors of the Bile Acid Transporter NTCP

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-15338-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Advancing Hepatitis B Virus Entry Inhibitors

Journal of Hepatology
Hepatology
2017English

A New Class of Hepatitis B and D Virus Entry Inhibitors, Proanthocyanidin and Its Analogs, That Directly Act on the Viral Large Surface Proteins

Hepatology
MedicineHepatology
2017English

Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities

Clinics in Liver Disease
Hepatology
2016English

A Function Essential to Viral Entry Underlies the Hepatitis B Virus "A" Determinant

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2009English

3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

The Impact of Hepatitis C Virus Entry on Viral Tropism

Cell Host and Microbe
ImmunologyMolecular BiologyCancer ResearchVirologyMicrobiologyMicrobiology Parasitology
2014English

Viral Hepatitis and Hepatitis B Antigen: Recent Advances

Postgraduate Medical Journal
Medicine
1974English

Detecting Hepatitis B Viral Amino Acid Sequence Mutations in Occult Hepatitis B Infections via Bayesian Partition Model

Journal of Proteomics & Bioinformatics
2013English

Viral Hepatitis B and Aplastic Anemia

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1975English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy